Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide. It provides products for use in cardiothoracic surgery, interventional procedure, and medicine transfusion. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems. It also provides interventional oncology devices, such as micro balloon catheters, micro catheters and guide wires, and drug-elutable beads; cardiopulmonary bypass systems comprising oxygenators with integrated arterial filters, heart-lung machines, and devices for operating a centrifugal pumps for extracorporeal life support systems; and thoracic vascular and abdominal vascular grafts. In addition, the company offers infusion systems; closed anticancer drug infusion systems; blood glucose monitoring systems, digital blood pressure monitors, digital thermometers, pulse oximeters, walking intensity monitors, body composition monitors, and HR joint meter/monitors; sprayable adhesion barrier gels; analgesics; pharmaceuticals and nutritional supplements; and peritoneal dialysis devices and fluids. Further, it provides other consumer healthcare products, such as basal thermometers, fall prevention products, oral care products, and urine test strips; and blood bag systems with leukocyte reduction filters, automated blood collection and blood component processing systems, pathogen reduction technology systems, centrifugal apheresis systems, cell expansion systems, and autologous cell processing devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.
Industry, Sector and Symbol
Industry Medical & hospital equipment
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone813-3374-8111
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$5.40 billion
Profitability
Miscellaneous
Employees23,319
Next Earnings Date11/14/2019 (Estimated)
OptionableNot Optionable
TERUMO CORP/ADR (OTCMKTS:TRUMY) Frequently Asked Questions
What is TERUMO CORP/ADR's stock symbol?
TERUMO CORP/ADR trades on the OTCMKTS under the ticker symbol "TRUMY."
When is TERUMO CORP/ADR's next earnings date?
Has TERUMO CORP/ADR been receiving favorable news coverage?
News articles about TRUMY stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. TERUMO CORP/ADR earned a news impact score of 0.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for TERUMO CORP/ADR.
Who are some of TERUMO CORP/ADR's key competitors?
Some companies that are related to TERUMO CORP/ADR include AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), GlaxoSmithKline (GSK), Stryker (SYK), Commonwealth Bank of Australia (CSLLY), Celgene (CELG), Becton Dickinson and (BDX), Bayer (BAYRY), Anthem (ANTM), Zoetis (ZTS), Intuitive Surgical (ISRG), Bayer (BAYN), Allergan (AGN) and Takeda Pharmaceutical (TAK).
What other stocks do shareholders of TERUMO CORP/ADR own?
Who are TERUMO CORP/ADR's key executives?
TERUMO CORP/ADR's management team includes the folowing people:
- Mr. David Brian Perez, Sr. Exec. Officer & Director (Age 60)
- Mr. Shinjiro Sato, Pres, CEO & Director
- Ryo Nishihata, Sr. Exec. Officer and Chief Accounting & Financial Officer
- Mr. Hiroaki Kasukawa, CTO & Exec. Officer
- Katsuya Takeuchi, Chief Information Officer & Exec. Officer
How do I buy shares of TERUMO CORP/ADR?
Shares of TRUMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is TERUMO CORP/ADR's stock price today?
One share of TRUMY stock can currently be purchased for approximately $32.04.
How big of a company is TERUMO CORP/ADR?
TERUMO CORP/ADR has a market capitalization of $24.34 billion and generates $5.40 billion in revenue each year. The company earns $715.23 million in net income (profit) each year or $0.94 on an earnings per share basis. TERUMO CORP/ADR employs 23,319 workers across the globe.View Additional Information About TERUMO CORP/ADR.
What is TERUMO CORP/ADR's official website?
How can I contact TERUMO CORP/ADR?
TERUMO CORP/ADR's mailing address is 2-44-1 Hatagaya Shibuya-ku, Tokyo M0, 151-0072. The company can be reached via phone at 813-3374-8111 or via email at [email protected]
MarketBeat Community Rating for TERUMO CORP/ADR (OTCMKTS TRUMY)
MarketBeat's community ratings are surveys of what our community members think about TERUMO CORP/ADR and other stocks. Vote "Outperform" if you believe TRUMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRUMY will underperform the S&P 500 over the long term. You may vote once every thirty days.
